"10.1371_journal.pone.0109823","plos one","2014-10-14T00:00:00Z","Lijun Gu; Ai Kawana-Tachikawa; Teiichiro Shiino; Hitomi Nakamura; Michiko Koga; Tadashi Kikuchi; Eisuke Adachi; Tomohiko Koibuchi; Takaomi Ishida; George F Gao; Masaki Matsushita; Wataru Sugiura; Aikichi Iwamoto; Noriaki Hosoya","Research Center for Asian Infectious Diseases, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan; Japan-China Joint Laboratory of Molecular Immunology and Molecular Microbiology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P. R. China; Division of Infectious Diseases, Advanced Clinical Research Center, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan; Department of Infectious Disease Control, International Research Center for Infectious Diseases, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan; Division of Infectious Diseases and Applied Immunology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P. R. China; Biotech Research and Development, Wakunaga Pharmaceutical Corporation, Hiroshima, Japan","Conceived and designed the experiments: LG NH AKT AI. Performed the experiments: LG NH AKT. Analyzed the data: LG NH TS WS. Contributed reagents/materials/analysis tools: MM. Contributed to the writing of the manuscript: LG NH AI. Provided clinical information and patient care: HN MK TK EA TK AI. Discussion: TI GFG.","A.I. has received grant support from Toyama Chemical Co. Ltd., astellas, ViiV Healthcare K.K., MSD K.K., Baxter through the University of Tokyo. A.I. has received speakerâ€™s honoraria/payment for manuscript from Eiken Chemical Co. Ltd., astellas, Toyama Chemical Co. Ltd, Torii Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd. and MSD. MM is an employee of Wakunaga Pharmaceutical Corporation which keeps a patent on PCR amplification sequence-specific oligonucleotide probes (SSOP) method. For the remaining authors none were declared. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","10","Lijun Gu","LG",14,TRUE,4,3,4,NA,TRUE,TRUE,FALSE,0,NA,FALSE
